Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Diethylcarbamazine | 90-89-1 | 99.8% | 199.29 | 1 ML
SDP

Catalog No. 5000438041
Encompass_Preferred

Diethylcarbamazine is an orally active microfilaricidal agent, effective in onchocerciasis and lymphatic filariasis. It reduces eosinophil trafficking to lung tissue, exhibiting anti-allergic effects. The compound ameliorates insulin resistance by lowering serum levels of leptin, TNF-α, IL-6, MCP-1, glucose, insulin, and triglycerides. It also enhances reactive oxygen intermediate expression by polymorphonuclear neutrophils, increases lymphocyte proliferation, and inhibits actinomycetoma lesion development. Research applications include bronchial asthma, insulin resistance, and infection.

  • Orally active microfilaricidal
  • Anti-allergic properties
  • Ameliorates insulin resistance
  • Modulates immune response
  • Inhibits actinomycetoma lesion development
  • Relevant for bronchial asthma, insulin resistance, and infection research

Catalog No. 50-004-38041 Supplier Medchemexpress LLC Supplier No. HY1264210MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Diethylcarbamazine is an orally active microfilaricidal agent, effective in onchocerciasis and lymphatic filariasis. It reduces eosinophil trafficking to lung tissue, exhibiting anti-allergic effects. The compound ameliorates insulin resistance by lowering serum levels of leptin, TNF-α, IL-6, MCP-1, glucose, insulin, and triglycerides. It also enhances reactive oxygen intermediate expression by polymorphonuclear neutrophils, increases lymphocyte proliferation, and inhibits actinomycetoma lesion development. Research applications include bronchial asthma, insulin resistance, and infection.

  • Orally active microfilaricidal
  • Anti-allergic properties
  • Ameliorates insulin resistance
  • Modulates immune response
  • Inhibits actinomycetoma lesion development
  • Relevant for bronchial asthma, insulin resistance, and infection research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.